VERSANT VENTURE CAPITAL VI, L.P. sold 14.5% of their position (334.80K shares) of LENZ THERAPEUTICS, INC. on the open market
Open‑market sale worth $10.11M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 6/20/2025ACC: 0000950170-25-088604
10% Owner
Since Jun 2021
-334.80K
Net shares
Net seller
$10.11M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
334.80K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−100K
Price / share
$29.95
Trade value
$3M
% of position
8.0%
6/18/2025
1.25M→1.15M
Common Stock
Indirect
Shares
−100.88K
Price / share
$30.35
Trade value
$3.06M
% of position
8.8%
6/20/2025
1.15M→1.05M
Common Stock
Direct
Shares
−133.92K
Price / share
$30.25
Trade value
$4.05M
% of position
6.4%
6/20/2025
2.10M→1.97M
Total
Net shares
−334.80K
Net value
-$10.11M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/18/2025 | S · Sale | −100K | $29.95 | $3M | 8.0% | 1.25M | 1.15M |
| Common Stock Indirect | 6/20/2025 | S · Sale | −100.88K | $30.35 | $3.06M | 8.8% | 1.15M | 1.05M |
| Common Stock Direct | 6/20/2025 | S · Sale | −133.92K | $30.25 | $4.05M | 6.4% | 2.10M | 1.97M |
| Total | −334.80K | -$10.11M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned842.16K
Total
842.16K indirect842.16K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 842.16K | Indirect |
| Total | 842.16K | 842.16K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported